Psychiatry and Neurology, Neurology · Marion, OH
NPI
1912193855
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
990 S Prospect St Ste 2
Marion, OH, 43302
Phone (740) 383-7833
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
3,327 services
Medicare patients, 2024
319
Average age 71
Drug cost, 2024
$1.0M
5,184 prescriptions
Company payments, 2025
$30.34
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Halina Pritula was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 314 times for 191 patients. In total Halina Pritula billed 3,327 services in 34 codes, and Medicare paid $83K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 314 | 191 | $12.75 | $4,004 |
| 99215 Office E&M - Established | Office | 242 | 112 | $127.66 | $31K |
| 99214 Office E&M - Established | Office | 172 | 105 | $78.29 | $13K |
| 95886 Electrical Nerve Conductivity | Office | 45 | 25 | $30.04 | $1,352 |
| 99205 Office E&M - New | Office | 32 | 32 | $158.94 | $5,086 |
| 95806 Sleep Study | Office | 26 | 26 | $29.15 | $758 |
| 99233 Hospital E&M - Subsequent | Facility | 25 | 20 | $91.85 | $2,296 |
| 99204 Office E&M - New | Office | 21 | 21 | $119.90 | $2,518 |
| 95810 Sleep Study | Office | 19 | 19 | $92.50 | $1,757 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $137.40 | $2,473 |
| 95811 Sleep Study | Office | 17 | 17 | $96.64 | $1,643 |
| 95910 Electrical Nerve Conductivity | Office | 13 | 13 | $103.64 | $1,347 |
By year: 2022 $126K for 8,326 services; 2023 $86K for 3,883 services; 2024 $83K for 3,327 services.
Medicare prescription drug claims, 2024
In 2024, the drug Halina Pritula prescribed most often to Medicare patients was Gabapentin, with 617 prescriptions and refills. In total Halina Pritula wrote 5,184 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 617 | 1,036 | 134 | $9,840 |
| Topiramate Generic | 276 | 487 | 55 | $2,980 |
| Donepezil Hcl Generic | 205 | 347 | 44 | $1,717 |
| Ropinirole Hcl Generic | 202 | 391 | 51 | $1,769 |
| Baclofen Generic | 181 | 331 | 46 | $2,862 |
| Trazodone Hcl Generic | 149 | 276 | 43 | $836 |
| Levetiracetam Generic | 145 | 263 | 36 | $4,178 |
| Tizanidine Hcl Generic | 144 | 227 | 38 | $1,867 |
| Memantine Hcl Generic | 130 | 220 | 33 | $3,378 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 116 | 116 | 14 | $3,902 |
| Lacosamide Generic | 115 | 139 | 11 | $7,253 |
| Rizatriptan Rizatriptan Benzoate | 114 | 116 | 30 | $3,024 |
| Escitalopram Oxalate Generic | 113 | 197 | 27 | $973 |
| Primidone Generic | 105 | 213 | 28 | $3,264 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 98 | 220 | 24 | $1,112 |
Brand drugs: 334 claims; generic drugs: 4,835 claims; opioid claims: 77.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Halina Pritula $30.34 ($30.34 in general payments such as food, travel and fees) from 1 company. The largest payer was Inspire Medical Systems, Inc. with $30.34.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 1 | $30.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.